Drug Release Control Articles & Analysis
26 news found
With Protheragen-ING’s microneedle technology, controlled drug delivery can be achieved using precise and efficient use of both hollow and solid structures made from any materials (silicons, metals or biodegradable polymers). ...
Oral thin films present a novel approach in drug delivery, offering ease in administration without the need for water and reducing risks associated with traditional dosage forms. ...
Lyophilized flash-release formulations are advanced drug delivery systems that incorporate the benefits of both lyophilization and flash-release technologies. “Whether customers are trying to develop a new drug or seeking to improve the release characteristics of an existing drug, our ...
To help pharmaceutical partners and academic institutions overcome the challenges of low bioavailability and unsustainable drug release in drug formations for glaucoma, Ace Therapeutics is proud to announce the unveiling of its cutting-edge drug delivery system development services for the treatment of glaucoma. ...
These hydrogels are pivotal in medical devices, regenerative medicine, drug delivery systems, 3D cell culture, and wound healing." Diverse Product Offering: Biopharma PEG’s multi-arm PEG products are available with various branching structures and functional groups to meet the specific needs of researchers and developers in the medical and bioorganic fields. ...
CD Formulation is making waves in the pharmaceutical industry with its innovative drug delivery technologies. With a focus on sustained and controlled release formulations, as well as liquid, semi-solid, injectable, and nanoformulations, CD Formulation is at the forefront of the industry's efforts to enhance drug efficacy. One of ...
CD Formulation, a leading pharmaceutical contract service company, has recently unveiled groundbreaking hydrogel microneedle patch technology aiming at increase the drug loading capacity and enhance drug delivery efficiency. The new technology represents a significant advancement in the field of transdermal drug delivery. ...
Typically, the structures of such polymers are designed to reduce their dispersion in solution, thereby improving their stability and controllability. They’re widely used as drug carriers mainly because of their ability to efficiently carry and release drug molecules, thereby improving drug bioavailability ...
By utilizing a combination of cutting-edge analytical techniques, CD Formulation is able to analyze the drug release kinetics, bioavailability, and pharmacokinetics of oral thin films with unprecedented accuracy. ...
Controlled-release drug delivery systems are designed to release medications at a desired rate and duration, ensuring consistent therapeutic levels in the body. ...
These microneedles are composed of a biocompatible material that dissolves upon insertion, allowing for controlled and targeted drug release. The dissolving microneedle preparation services offered by CD Formulation provide a comprehensive solution for pharmaceutical companies looking to optimize drug delivery. ...
CD Formulation understands the critical importance of selecting the right excipients, polymer matrices, and drug loading techniques to ensure optimal drug stability and release. ...
Transdermal patches, yet another key service area of CD Formulation, provide controlled drug release through the skin. They offer several advantages, including sustained drug delivery, improved patient compliance, and reduced side effects. ...
Microspheres are tiny spherical particles that allow for controlled drug release, ensuring a sustained therapeutic effect over an extended period of time. ...
Microspheres, tiny spherical particles typically ranging from 1 to 100 microns in diameter, offer immense potential for targeted drug delivery. By encapsulating active pharmaceutical ingredients (APIs) within these microspheres, drugs can be delivered directly to specific tissues or organs, resulting in improved therapeutic efficacy and reduced side effects. ...
“Our new collection of pharmaceutical excipients covers a wide range of dosage forms, including liquids, solids, semi-solids, controlled-release, transdermal, mucosal, and micro drug delivery systems. ...
(NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced the initiation of the first Phase 3 clinical trial of its lead candidate CTx-1301, a novel, investigational, trimodal, ...
(NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced the completion of its study assessing the effect of food on absorption of its lead candidate CTx-1301, an investigational ...
Choosing the most appropriate delivery system has tremendous benefits, including but not limited to controlled release of drugs, enhanced drug targeting, improved solubility and bioavailability of drugs. In the past decade, several new drug delivery systems have been formulated, in the hope to ...
About CTx-2103 CTx-2103 is a novel, trimodal, extended-release tablet of buspirone being developed to incorporate the Cingulate’s proprietary PTR™ drug delivery platform, and is being studied for the treatment of anxiety and/or anxiety-related disorders. ...